News

In a report released yesterday, Joshua Schimmer from Cantor Fitzgerald maintained a Buy rating on Aardvark Therapeutics, Inc. (AARD – Research Report), with a price target of $50.00. The company ...
The Aardvark utilized two Pratt & Whitney TF30-P-111s with 25,100 pounds of thrust when deploying afterburners – the first fighter-bomber to have afterburning turbofans. The range of the warbird ...
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic ...
Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight ...
MIPI RFFE SPI I2C Slave interface provides full support for the two-wire MIPI RFFE synchronous serial interface with SPI and I2C overlay, compatible with RFFE, SPI and I2C specification. Through its ...
Shares of United Airlines Holdings, Inc. UAL rose sharply in today's pre-market trading following first-quarter results. The company reported adjusted first-quarter earnings of 91 cents per share ...
The company has a new South Africa trip to see niche nocturnal mammals, such as the aardvark and aardwolf. Wayfairer Travel reports a 35% rise in demand for night safaris in Africa compared to ...
Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Aardvark Therapeutics, Inc. before investing. In this article, we go over a few ...